Fulgent Genetics
FLGT
37 hedge funds and large institutions have $38.1M invested in Fulgent Genetics in 2017 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 9 increasing their positions, 13 reducing their positions, and 8 closing their positions.
25% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 8
7% more capital invested
Capital invested by funds: $35.5M → $38.1M (+$2.66M)
2.41% more ownership
Funds ownership: 17.35% → 19.75% (+2.4%)
0% more funds holding
Funds holding: 37 → 37 (0)
31% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 13
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
William Blair Investment Management
Chicago,
Illinois
|
+$6.85M |
| 2 |
BlackRock
New York
|
+$1.64M |
| 3 |
SC
Scholtz & Company
Stamford,
Connecticut
|
+$1.05M |
| 4 |
State Street
Boston,
Massachusetts
|
+$592K |
| 5 |
William Blair & Company
Chicago,
Illinois
|
+$311K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$1.27M |
| 2 |
Alyeska Investment Group
Chicago,
Illinois
|
-$1.18M |
| 3 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
-$889K |
| 4 |
USAA
United Services Automobile Association
San Antonio,
Texas
|
-$390K |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$367K |
FLGT Hedge Fund Activity: Q1 2017 in Review
37 of the 4,034 institutional investors tracked by Wall St. Rank reported a position in Fulgent Genetics (FLGT) for Q1 2017, worth a combined $38.1M — up 7.5% from $35.5M a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new FLGT positions and 8 closed out — a net gain of 2 holders — while 9 added to existing stakes and 13 trimmed.
The largest buyer was William Blair Investment Management, opening a new position worth an estimated $6.85M. The largest seller was Cormorant Asset Management, cutting an estimated $1.27M.
- 37 institutional investors held Fulgent Genetics (FLGT) as of Q1 2017, unchanged from Q4 2016.
- Funds reported $38.1M of Fulgent Genetics stock for Q1 2017, up 7.5% quarter-over-quarter.
- 10 funds opened new Fulgent Genetics positions in Q1 2017 and 8 closed out, a net change of +2 holders.
- The largest Fulgent Genetics buyer in Q1 2017 was William Blair Investment Management, an estimated $6.85M added.
- The largest Fulgent Genetics seller in Q1 2017 was Cormorant Asset Management, an estimated $1.27M sold.
Based on aggregated 13F filings for Q1 2017.